Dr. Sutton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2200 E 3rd St
Suite 100
Chattanooga, TN 37404Phone+1 423-698-1844- Is this information wrong?
Summary
- Dr. Gregory Sutton is an oncologist and hematologist in Chattanooga, TN and is affiliated with Parkridge Medical Center, Memorial, and Erlanger hospital systems. He received his medical degree from University of Tennessee Health Science Center College of Medicine and has been in practice 8 years. He is experienced in all solid oncology tumors, amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. He is also a clinical trial investigator in collaboration with Sarah Canon Research Institution.
Education & Training
- University of TennesseeFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of Tennessee College of Medicine at ChattanoogaResidency, Internal Medicine, 2009 - 2012
- University of Tennessee Health Science Center College of MedicineClass of 2009
Certifications & Licensure
- GA State Medical License 2021 - 2024
- TN State Medical License 2011 - 2024
- AL State Medical License 2020 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients Start of enrollment: 2009 Mar 01
- Chemotherapy in Treating Patients With Sarcoma of the Uterus Start of enrollment: 2000 May 01
- Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsGrade and Prognosis in Localized Primary AngiosarcomaManjari Pandey, Gregory R. Sutton, Smith Giri, Michael Gary Martin> ;Clinical Breast Cancer. 2015 Aug 1
- 25 citationsEzatiostat hydrochloride for the treatment of myelodysplastic syndromesDaruka Mahadevan, Gregory Ryan Sutton> ;Expert Opinion on Investigational Drugs. 2015 Apr 8
- 32 citationsPhase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with ...Daruka Mahadevan, Gregory Ryan Sutton, Rafael Arteta-Bulos, Chris Bowden, PJ Miller, Rachel Elizabeth Swart, Mark S. Walker, Paul Haluska, Pamela N. Munster, John L. M...> ;Cancer Chemotherapy and Pharmacology. 2014 Jan 4
Hospital Affiliations
- Parkridge Medical CenterChattanooga, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: